US Patent 10815305 Methods of treating inflammatory conditions
Patent 10815305 was granted and assigned to Regeneron Pharmaceuticals on October, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10815305 Methods of treating inflammatory conditions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
